Intra-tumoral BT-001 injection in combination with IV pembrolizumab was well tolerated with a manageable safety profile. Tumor shrinkage was observed in both injected and non-injected lesions. BT-001 ...
Authors: C. Lebbe, R. Bahleda, E. Ezine, B. Baroudjian, M. Sakkal, E. Rowinski, A. Vinceneux, S. Champiat, K. Bidet Huang, N. Stojkowitz, H. Makhloufi, A. Sadoun, A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results